Le Lézard
Classified in: Ebola virus, Covid-19 virus

Worldwide mRNA Vaccine and Therapeutics Industry to 2030 - Featuring AstraZeneca, Bayer and Moderna Among Others - ResearchAndMarkets.com


The "Global mRNA Vaccine and Therapeutics Market - Analysis By Product, End User, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of Covid-19 (2021-2030)" report has been added to ResearchAndMarkets.com's offering.

The mRNA technology finds its applications in many diseases including the Covid-19 vaccine. The market for mRNA is mostly driven by the Covid-19 vaccine besides its major usage in cancer therapies. With the mutation of the coronavirus and possible spread of variants of the virus, the mRNA companies are actively engaged in developing next generation vaccines for Covid-19.

The Global mRNA Vaccine and Therapeutic Market is estimated at USD 29672.31 Million in the year 2025. The growing occurrences of chronic and infectious diseases, such as diabetes, HIV, cancer and CVDs, is one of the major key factors driving the growth of the market. The growing demand for therapeutic medicines and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV) and other viral infections as well as inability of traditional vaccine approach to find vaccines at the critical time are also providing a boost to the market growth. Compared to conventional medicines, mRNA vaccines and Therapeutics are developed with the help of advanced technologies which are more effective against pathogens, have higher effectiveness, improved immunogenicity and require less cost to produce. Moreover, developments in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are also creating a positive outlook for the market growth.

Covid-19 vaccines are expected to hold largest share of mRNA Vaccine and Therapeutics market. The standardisation of the cancer treatment segment, during the forecast period 2026-2030, is expected to be the largest contributor to the market growth. The major reason is the increase in the number of cancer patients around the world and it becomes imperative to have a set of standards for its treatment.

North America holds the largest share of the mRNA vaccines and therapeutics market for non-Covid-19 vaccines due to the growing need to develop transformative therapeutics, increasing fund infusions, a favorable regulatory environment, and massively growing attention to establish precision medicine, among others. Rising prevalence of cancer and other diseases among the developing economies of Asia region is augmenting the demand of mRNA Vaccine and Therapeutics in APAC region.

Companies Mentioned

Scope of the Report

Key Topics Covered:

1. Report Scope and Methodology

2. Strategic Recommendations

3. mRNA Vaccine and Therapeutics Market: Product Outlook

4. Global mRNA Vaccine and Therapeutics Market: Sizing and Forecast

5. Global mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User

6. Global mRNA Vaccine and Therapeutics Market: Regional Analysis

7. North America mRNA Vaccine and Therapeutics Market : An Analysis (2021-2030)

8. Europe mRNA Vaccine and Therapeutics Market : An Analysis (2021-2030)

9. Asia Pacific mRNA Vaccine and Therapeutics Market : An Analysis (2021-2030)

10. Global mRNA Vaccine and Therapeutics Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Trends

11. Market Attractiveness

11.1 Market Attractiveness Chart of Global mRNA Vaccine and Therapeutics Market - By Product, 2030

11.2 Market Attractiveness Chart of Global mRNA Vaccine and Therapeutics Market - By End User, 2030

11.3 Market Attractiveness Chart of Global mRNA Vaccine and Therapeutics Market - By Region, 2030

12. Competitive Landscape

12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers

13. mRNA Vaccine and Therapeutics Pipeline Development

13.1 mRNA vaccine development pipeline for infectious diseases

13.2 mRNA cancer therapies in development

13.3 mRNA-based protein therapeutics in development

14. Regulatory Compliance

15. Company Analysis

For more information about this report visit https://www.researchandmarkets.com/r/vnl6nj


These press releases may also interest you

21 mar 2019
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...



News published on and distributed by: